- Building a profitable and cash generative business
- Developing and commercialising low-risk late stage products for unmet medical need
- Partnering all of our drug candidates; selective investment in our in-house products
- Highly experienced executive and senior management team
One of the UK’s leading development stage pharmaceutical companies, Vernalis takes promising product candidates along a commercially-focused path to market. We derive pipeline candidates both from successful collaborations with a number of global pharmaceutical businesses and our own research activities. Our pipeline reflects our strategy and is split between our later stage commercial pipeline and our NCE portfolio.
See where Vernalis is now
View the pipeline, plus our staffing and research capabilities
Clear direction for the competitive biotech sector
What therapeutic areas are we targeting, and what strategies do we rely on to achieve results?
Experienced, successful, engaged leadership
For a company this size, our
directors and senior management stand out
Where does Vernalis come from?
The history of the organisation, and the relationships we’ve developed
Interested in working with us?
Check out current vacancies and see the specialisations we are looking for
We take our responsibilities seriously
Good governance and good practice are inherent in all our operations
Tuesday, 09 April 2013
Vernalis plc (LSE: VER) today announces its audited results for the year ended 31 December 2012